GraftLife AB
Developing patented ex-vivo perfusion technology to increase transplantable kidneys globally.
Oversikt
- 3
- Ansatte
- 1.6mill SEK
- Omsetning
- 2019
- Grunnlagt
Nøkkelbeslutningstakere
Magnus Nilsson
CEO
Beskrivelse
UGLK Science AB is a Swedish biotechnology company focused on solving the critical shortage of transplantable donor kidneys. They have developed a patented ex-vivo kidney perfusion system designed for the reconditioning and evaluation of organs. This innovative system comprises a durable perfusion m...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559194216301
Beslutningstakere
1 kontakter i FunnelfeedrMagnus Nilsson
CEO
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Vitrosorb AB
5–9 ansatteSwedish medical device company solving organ transplant barriers.
Vitrosorb Technology AB
Swedish medical device company solving critical healthcare needs via apheresis.
Xvivo Perfusion Aktiebolag
50–99 ansatteWorld leader developing technology to extend organ life for transplantation.
Carnamedica AB
0 ansattePolish company providing specialized organ perfusion technology for transplant teams.
GLYCOREX TRANSPLANTATION AB (PUBL)
10–19 ansatteDevelops technology to remove blood antibodies for transplants and disease.
Utforsk mer
Spørsmål om GraftLife AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo